Compounds > ly 300164
Page last updated: 2024-09-05

ly 300164 and quinoxalines

ly 300164 has been researched along with quinoxalines in 5 studies

Compound Research Comparison

Studies
(ly 300164)		Trials
(ly 300164)		Recent Studies (post-2010)
(ly 300164)		Studies
(quinoxalines)		Trials
(quinoxalines)		Recent Studies (post-2010) (quinoxalines)
737129,8876253,095

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's3 (60.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Deverill, M; Hoo, KH; Iyengar, S; Li, DL; Ornstein, PL; Simmons, RM1
Vanover, KE1
Jiang, L; Kang, J; Nedergaard, M; Xu, J1
Barkoczy, J; Gigler, G; Gressens, P; Harsing, LG; Kapus, G; Kertesz, S; Levay, G; Medja, F; Spedding, M; Szenasi, G; Villa, P; Williamson, T1
Aujla, PK; Fishman, R; Jensen, FE; Rakhade, SN; Sucher, NJ; Zhou, C1

Other Studies

5 other study(ies) available for ly 300164 and quinoxalines

ArticleYear
Kainate GluR5 receptor subtype mediates the nociceptive response to formalin in the rat.
    Neuropharmacology, 1998, Volume: 37, Issue:1

    Topics: Animals; Benzodiazepines; Excitatory Amino Acid Antagonists; Formaldehyde; Humans; Isoquinolines; Male; Pain Threshold; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Kainic Acid; Tetrazoles

1998
Interaction of ethanol with excitatory amino acid receptor antagonists in mice.
    European journal of pharmacology, 1999, Mar-05, Volume: 368, Issue:2-3

    Topics: Animals; Ataxia; Behavior, Animal; Benzodiazepines; Central Nervous System Depressants; Chlordiazepoxide; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Interactions; Ethanol; Excitatory Amino Acid Antagonists; Hypnotics and Sedatives; Isoquinolines; Male; Mice; Muscle Relaxation; Pentobarbital; Piperazines; Pregnanolone; Psychomotor Performance; Quinoxalines; Receptors, Glutamate; Tetrazoles

1999
A kainate receptor increases the efficacy of GABAergic synapses.
    Neuron, 2001, Volume: 30, Issue:2

    Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Benzoates; Benzodiazepines; Cyclic AMP-Dependent Protein Kinases; Enzyme Inhibitors; Evoked Potentials; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; gamma-Aminobutyric Acid; Glycine; Hippocampus; In Vitro Techniques; Interneurons; Kainic Acid; Neurons; Protein Kinase C; Pyramidal Cells; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Kainic Acid; Staurosporine; Synapses; Tetradecanoylphorbol Acetate; Tetrodotoxin

2001
The effects of AMPA receptor antagonists in models of stroke and neurodegeneration.
    European journal of pharmacology, 2005, Sep-05, Volume: 519, Issue:1-2

    Topics: Animals; Animals, Newborn; Anticonvulsants; Benzodiazepines; Brain; Brain Ischemia; Cell Survival; Chickens; Cortical Spreading Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Electroshock; Excitatory Amino Acid Antagonists; Infarction, Middle Cerebral Artery; Male; Mice; Mice, Inbred Strains; Motor Neurons; Nerve Degeneration; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Retina; Seizures; Stroke

2005
Early alterations of AMPA receptors mediate synaptic potentiation induced by neonatal seizures.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2008, Aug-06, Volume: 28, Issue:32

    Topics: Animals; Animals, Newborn; Anticonvulsants; Benzodiazepines; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cyclic AMP-Dependent Protein Kinases; Disease Susceptibility; Enzyme Activation; Epilepsy; Excitatory Postsynaptic Potentials; Fructose; Hypoxia; Male; Phosphorylation; Protein Kinase C; Quinoxalines; Rats; Rats, Long-Evans; Receptors, AMPA; Synapses; Topiramate

2008